Panbela Therapeutics PBLA, a clinical stage biopharmaceutical company, gained almost 37.5% in pre-market hours on Apr 12. This occurred after the company regained its rights to develop and ...

Panbela Therapeutics Inc (PBLA) secured a $12 million strategic loan commitment from Napp Capital, which represents both financial backing and a potential clinical alliance. The company's lead program ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares ...

MINNEAPOLIS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet ...

The latest price target for Panbela Therapeutics (OTCEM:PBLA) was reported by HC Wainwright & Co. on August 15, 2024. The analyst firm set a price target for $0.00 expecting PBLA to fall to within 12 ...

Short interest in Panbela Therapeutics Inc (OTC:PBLA) decreased during the last reporting period, falling from 420.00 to 324.00. This put 0.01% of the company's publicly available shares short. Short ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--The Professional Box Lacrosse Association (PBLA) have announced the seven initial markets who will host teams for their inaugural lacrosse season, beginning December ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--The Professional Box Lacrosse Association (PBLA) today announced the launch of its most recent expansion team in Salem, Virginia, in the Roanoke Valley region. The ...

MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (Panbela), a clinical stage company ...